Skip to main content
# Title Department Research Year
101 Design and synthesis of new 1, 2, 4-oxadiazole/quinazoline-4-one hybrids with antiproliferative activity as multitargeted inhibitors Department of Pharmaceutical Organic Chemistry 2024
102 Evaluating anthelmintic, anti‑platelet, and anti‑coagulant activities, and identifying the bioactive phytochemicals of Amaranthus blitum L. Department of Pharmacognosy 2024
103 Mesenchymal stem cell therapy in diabetic foot ulcer: An updated comprehensive review Department of Microbiology and Immunology 2024
104 Design, synthesis, and molecular docking of novel 1,3, 4-triaryl pyrazole derivatives bearing methylsulfonyl moiety with anticancer activity through dual targeting CDK2 and COX-2 enzymes Department of Medicinal Chemistry 2024
105 Tetrahydro-(2H)-1,3,5-thiadiazine-2-thione (THTT), A Versatile Carrier System for Targeting Cell Cycle Checkpoint Pathways with Potential Anticancer Activities Department of Medicinal Chemistry 2024
106 Methylene blue-assisted molecularly-imprinted film modified nitrogen and sulfur co-doped molybdenum carbide for simultaneous electrochemical determination of two hepatotoxic drugs Department of Pharmaceutical Analytical Chemistry 2024
107 Bioassay-guided isolation and in Silico characterization of cytotoxic compounds from Hemimycale sp. Sponge targeting A549 lung cancer cells Department of Pharmaceutical Organic Chemistry 2024
108 ZIF-12-derived nitrogen doped porous carbon nanosheets-functionalized with silver nanoparticles for ratiometric molecularly-imprinted electrochemical sensing of D-penicillamine Department of Pharmaceutical Analytical Chemistry 2024
109 Highly selective fluorometric detection of streptokinase via fibrinolytic release of photoluminescent carbon dots integrated into fibrin clot network Department of Pharmaceutical Analytical Chemistry 2024
110 Convenient synthesis and X-ray determination of 2-amino-6H-1,3,4-thiadiazin-3-ium bromides endowed with antiproliferative activity Department of Pharmaceutical Organic Chemistry 2024